Positron emission tomographic imaging of cardiac sympathetic innervation and function
- National Institutes of Health, Bethesda, MD (USA)
Sites of uptake, storage, and metabolism of ({sup 18}F)fluorodopamine and excretion of ({sup 18}F)fluorodopamine and its metabolites were visualized using positron emission tomographic (PET) scanning after intravenous injection of the tracer into anesthetized dogs. Radioactivity was concentrated in the renal pelvis, heart, liver, spleen, salivary glands, and gall bladder. Uptake of 18F by the heart resulted in striking delineation of the left ventricular myocardium. Pretreatment with desipramine markedly decreased cardiac positron emission, consistent with dependence of the heart on neuronal uptake (uptake-1) for removal of circulating catecholamines. In reserpinized animals, cardiac positron emission was absent within 30 minutes after injection of ({sup 18}F)-6-fluorodopamine, demonstrating that the emission in untreated animals was from radioactive labeling of the sympathetic storage vesicles. Decreased positron emission from denervated salivary glands confirmed that the tracer was concentrated in sympathetic neurons. Radioactivity in the gall bladder and urinary system depicted the hepatic and renal excretion of the tracer and its metabolites. Administration of tyramine or nitroprusside increased and ganglionic blockade with trimethaphan decreased the rate of loss of myocardial radioactivity. The results show that PET scanning after administration of ({sup 18}F)fluorodopamine can be used to visualize sites of sympathetic innervation, follow the metabolism and renal and hepatic excretion of catecholamines, and examine cardiac sympathetic function.
- OSTI ID:
- 6809550
- Journal Information:
- Circulation; (USA), Journal Name: Circulation; (USA) Vol. 81:5; ISSN 0009-7322; ISSN CIRCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
6-[Fluorine-18]Fluorodopamine pharmacokinetics and dosimetry in humans
Dosimetric estimates for clinical positron emission tomographic scanning after injection of ( sup 18 F)-6-fluorodopamine
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
ALKALOIDS
AMINES
ANIMALS
ANTIHYPERTENSIVE AGENTS
AROMATICS
AUTONOMIC NERVOUS SYSTEM
AUTONOMIC NERVOUS SYSTEM AGENTS
AZAARENES
AZOLES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CARDIOTONICS
CARDIOVASCULAR AGENTS
CARDIOVASCULAR SYSTEM
COMPUTERIZED TOMOGRAPHY
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
DISTRIBUTION
DOGS
DOPAMINE
DRUGS
EMISSION COMPUTED TOMOGRAPHY
EVALUATION
FLUORINE 18
FLUORINE ISOTOPES
HEART
HETEROCYCLIC COMPOUNDS
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INDOLES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
MAMMALS
METABOLISM
METABOLITES
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NEUROREGULATORS
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PHENOLS
POLYPHENOLS
POSITRON COMPUTED TOMOGRAPHY
PYRROLES
RADIOISOTOPES
RESERPINE
SYMPATHOLYTICS
SYMPATHOMIMETICS
TISSUE DISTRIBUTION
TOMOGRAPHY
TYRAMINE
UPTAKE
VERTEBRATES